Histogenics and FDA Continue to Discuss NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway Genetics Investing
Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test Medical Device Investing
Pluristem to Present First Cohort Data from PLX-R18 Hematological Study at ASH Annual Meeting Genetics Investing
Mesoblast Reports First Quarter Ended September 30, 2018 Financial Results and Operational Highlights Genetics Investing